BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
11/12/2024 12:23:34 PM | Browse: 157 | Download: 635
 |
Received |
|
2024-06-27 04:01 |
|
Peer-Review Started |
|
2024-06-27 04:01 |
|
First Decision by Editorial Office Director |
|
2024-08-01 23:47 |
|
Return for Revision |
|
2024-08-02 00:06 |
|
Revised |
|
2024-08-03 03:50 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2024-08-13 03:01 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2024-08-13 09:25 |
|
Articles in Press |
|
2024-08-13 09:25 |
|
Edit the Manuscript by Language Editor |
|
2024-08-22 21:09 |
|
Typeset the Manuscript |
|
2024-08-28 06:06 |
|
Publish the Manuscript Online |
|
2024-11-12 12:23 |
| ISSN |
1948-5204 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Oncology |
| Manuscript Type |
Editorial |
| Article Title |
Gene targets with therapeutic potential in hepatocellular carcinoma
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Syifaus Shodry, Yuliono Trika Nur Hasan, Iwal Reza Ahdi and Zulvikar Syambani Ulhaq |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Zulvikar Syambani Ulhaq, MD, PhD, Research Scientist, Research Center for Preclinical and Clinical Medicine, National Research and Innovation Agency Republic of Indonesia, Cibinong Science Center, Jl. Raya Jakarta-Bogor, Cibinong 16911, Indonesia. zulhaq@kedokteran.uin-malang.ac.id |
| Key Words |
Hepatocellular carcinoma; EZH2; Target genes; Biomarkers; Potential therapeutic |
| Core Tip |
Hepatocellular carcinoma (HCC) is one of the leading causes of cancer-related deaths due to late diagnosis and high recurrence rates. Key biomarkers like EZH2 and FABP5, along with other genetic biomarkers provide insights into HCC progression and potential therapeutic targets. |
| Publish Date |
2024-11-12 12:23 |
| Citation |
Shodry S, Hasan YTN, Ahdi IR, Ulhaq ZS. Gene targets with therapeutic potential in hepatocellular carcinoma. World J Gastrointest Oncol 2024; 16(12): 4543-4547 |
| URL |
https://www.wjgnet.com/1948-5204/full/v16/i12/4543.htm |
| DOI |
https://dx.doi.org/10.4251/wjgo.v16.i12.4543 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
